1. Back to Working Groups

Monogenic Network

The Monogenic Network is comprised of the (i) Data Generation Working Group and the (ii) Data Analysis Working Group, and studies patients and families with known and potential new monogenic causes of Parkinson’s disease.

About the Monogenic Network

The Monogenic Network aims to identify novel genetic causes of monogenic Parkinson’s disease (PD) – forms of PD where pathogenic variants in a single PD-linked gene are considered causative of the disease. Leveraging GP2’s global network of researchers contributing patient samples, the Monogenic Network has been recruiting thousands of patients and relatives from families in whom a monogenic cause is known or suspected, with an emphasis on families from underrepresented populations. 

Pathogenic variants in all currently known PD genes have been found in various populations around the globe; however, some occur at highly variable and population-specific frequencies, the most striking example being the p.G2019S variant in the LRRK2 gene. Additionally, population-specific hereditary forms of PD or parkinsonism may exist, as exemplified by X-linked dystonia-parkinsonism, a condition exclusively present in patients of Filipino ancestry. 

The Data Generation Working Group collects families and single cases, as well as parent-offspring trios. Samples undergo short-read whole-genome sequencing and, in a subset of cases, long-read whole-genome sequencing. Clinical data are collected in a standardized fashion and undergo quality control. The Data Analysis Working Group analyzes this genomic data for the presence of potentially pathogenic variants, which are then validated in silico and in vitro. 

The Monogenic Network invites collaborators to participate in the Network's open meetings once a month (first Friday of the month at 1:30 pm CET). 

Meet the leads & co-leads

Lead

Christine Klein, MD

University of Luebeck | Germany

Co-Lead

Niccolò Emanuele Mencacci, MD, PhD

Northwestern University, Northwestern University | Chicago, IL, USA

Co-Lead

Joanne Trinh, PhD

University of Lübeck | Luebeck, Germany

Meet the participants

Member

Shen-Yang Lim

University of Malaya | Malaysia

Member

Melina Ellis

Concord Hospital | Australia

Member

Lara Lange, MD

University of Lübeck and University Medical Center Schleswig-Holstein | Bethesda, MD, USA

Member

Ignacio Juan Keller Sarmiento, MD

Northwestern University | USA

Member

Harutyun Madoev

University of Luebeck | Germany

Member

Ai Huey Tan, MD, PhD

University of Malaya | Kuala Lumpur, Malaysia

Member

Enza Maria Valente, MD, PhD

University of Pavia, IRCCS Mondino Foundation | Milano, Italy

Member

Micol Avenali, MD, PhD

University of Pavia, Fondazione Istituto Neurologico Nazionale Casimiro Mondino | Pavia, Italy

Member

Zih-Hua Fang, PhD

The German Center for Neurodegenerative Diseases | Tübingen, Germany

Member

Azlina Ahmad-Annuar

University of Malaya | Malaysia

Member

Cholpon Shambetova, MD

Kyrgyz State Medical Academy, University of Luebeck | Bishkek, Kyrgyzstan

Member

Kishore Kumar, PhD

Garvan Institute of Medical Research and Concord Repatriation General Hospital | Australia

Member

Soraya Bardien, PhD

Stellenbosch University | Cape Town, South Africa

Member

Thomas Gasser, MD

University of Tübingen | Germany

Member

Peter Heutink, PhD

unknown | Montieri, Italy

Member

Alexander Balck, MD

University of Lübeck | Germany

Member

Paola Dimartino, PhD

University of Pavia, unknown | Pavia, Italy

Member

Caterina Galandra, PhD

IRCCS Mondino Foundation | Italy

Member

Carolin Gabbert, PhD

the University of Lübeck | Lübeck, Germany

Member

Laura Rudaks, MBBS

University of Sydney, Concord Repatriation General Hospital, Garvan Institute of Medical Research | Sydney, Australia

Member

Dennis Yeow, BSc,MBBS

NeuRA | Sydney, Australia

Milestones

Active

  • Monogenic Network website and Monogenic Portal developed and online
  • Collected ~4,000 samples eligible for inclusion into the Monogenic Network
  • Recruited over 70 centers to participate
  • Developed and established genetic analysis pipeline
  • Welcomed over 15 visitors and trainees at different research institutions of members of the Monogenic Network
  • Established the Return of results working group within the Monogenic Network